Results 21 to 30 of about 6,064 (157)
Allergic bronchopulmonary aspergillosis: Indian scenario
Indian Journal of Allergy Asthma and Immunology, 2019 Aspergillus is ubiquitous, occurring in mycelial form and grows at 15-530C and humid conditions. Pulmonary aspergillosis is a clinical spectrum of lung disease caused by the fungus Aspergillus.
Rajendra Prasad +2 more
doaj +1 more source
Management of allergic bronchopulmonary aspergillosis: a review and update
Therapeutic Advances in Respiratory Disease, 2012 Since the first description of allergic bronchopulmonary aspergillosis (ABPA) in the 1950s there have been numerous studies that have shed light on the characteristics and immunopathogenesis of this disease.
Mahboobeh Mahdavinia, Leslie C. Grammer
doaj +1 more source
Allergy, EarlyView.IL‐33 induces inflammatory gene signatures in eosinophils, characterised by the upregulation of cell surface markers, inflammatory mediators and regulatory factors, all of which were also observed in nasal polyp‐derived eosinophils. Ox‐LDL and complement fragments (C3a and C5a) promote eosinophil adhesion and survival.
Emiko Matsuyama +16 more
wiley +1 more source
Demographic and Comorbidity Associations With Disease Severity and Bony Dehiscence in AFRS
Laryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.ABSTRACT Objective(s) The purpose of this study is to explore and describe possible demographic factors and comorbidities as they relate to disease severity of allergic fungal rhinosinusitis (AFRS) on initial presentation. Methods A retrospective review was conducted on 153 patients with AFRS seen at a tertiary care center. Demographics, comorbidities,
Diana Bigler +6 more
wiley +1 more source
Clinical Case Reports, 2021 As diagnostic algorithms for cystic fibrosis (CF) continue to evolve, education of general practitioners is essential to prevent delayed diagnosis of CF and allow prompt referral to CF centers.
Patricia Choi +2 more
doaj +1 more source
Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang +3 more
wiley +1 more source
Allergic bronchopulmonary aspergillosis with coexistant aspergilloma: a case report
Journal of Medical Case Reports, 2010 Introduction The coexistence of allergic bronchopulmonary aspergillosis and aspergilloma is rare. Case presentation We present the case of a 56-year-old Caucasian man who worked as a farmer, with infiltrates in the right lower and middle lung lobes ...
Kern Izidor, Lopert Anton
doaj +1 more source
Journal of Genetic Engineering and Biotechnology, 2022 Background Among the most common causes of invasive aspergillosis and acute bronchopulmonary aspergillosis is Aspergillus fumigatus. Transmission with A.
Darakshan Jabin, Ajay Kumar
doaj +1 more source
Respiratory Medicine Case Reports, 2019 A 56-year-old woman was referred to our hospital for recurrent asthma of 20 years duration. She was diagnosed as having allergic bronchopulmonary aspergillosis on the basis of clinical symptoms, peripheral blood eosinophilia, elevated total serum ...
Shuko Hirota +6 more
doaj +1 more source